Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Endogenous Opioid Peptides in HIV-associated Chronic Widespread Pain
NCT04787848Recruiting
- Sponsor
- Florida International University
- Start
- Nov 2021
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of methylnaltrexone in Chronic widespread pain (CWP) (4 arms), sponsored by Florida International University. Primary endpoint: Quantitative sensory testing. Started Nov 2021; status: recruiting.
02
Drugs
methylnaltrexone
03
Conditions
Chronic widespread pain (CWP)
Beyond the preview
Go deeper on NCT04787848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04787848.